Study to Evaluate the Efficacy of Dronabinol (Marinol) as Add-On Therapy for Patients on Opioids for Chronic Pain
PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment
30
Participants
Timeline
Start Date
April 30, 2001
Primary Completion Date
April 30, 2006
Study Completion Date
April 30, 2006
Conditions
Chronic Pain
Interventions
DRUG
Marinol (dronabinol)
Trial Locations (1)
02115
Brigham and Women's Hospital, Boston
All Listed Sponsors
collaborator
Solvay Pharmaceuticals
INDUSTRY
lead
Brigham and Women's Hospital
OTHER
NCT00153192 - Study to Evaluate the Efficacy of Dronabinol (Marinol) as Add-On Therapy for Patients on Opioids for Chronic Pain | Biotech Hunter | Biotech Hunter